The University of Chicago Header Logo

Connection

Tammy Utset to Adult

Back to Details
This is a "connection" page, showing publications Tammy Utset has written about Adult.
Tammy Utset
Connection Strength
0.334
Adult
  1. Significance of chronic tachycardia in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013 May; 65(5):827-31.
    View in: PubMed
    Score: 0.030
  2. Correlates of sleep abnormalities in systemic lupus: a cross-sectional survey in an urban, academic center. J Clin Rheumatol. 2013 Jan; 19(1):7-13.
    View in: PubMed
    Score: 0.029
  3. A study of racial/ethnic differences in treatment preferences among lupus patients. Rheumatology (Oxford). 2012 Sep; 51(9):1697-706.
    View in: PubMed
    Score: 0.028
  4. Correlates of formal work disability in an urban university systemic lupus erythematosus practice. J Rheumatol. 2008 Jun; 35(6):1046-52.
    View in: PubMed
    Score: 0.021
  5. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Arthritis Rheum. 2007 Jun 15; 57(5):845-50.
    View in: PubMed
    Score: 0.020
  6. Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol. 2006 Mar; 33(3):531-8.
    View in: PubMed
    Score: 0.018
  7. Neuropsychologic functioning and health status in systemic lupus erythematosus: does ethnicity matter? J Clin Rheumatol. 2005 Oct; 11(5):250-6.
    View in: PubMed
    Score: 0.018
  8. Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial. Lancet Rheumatol. 2024 Mar; 6(3):e168-e177.
    View in: PubMed
    Score: 0.016
  9. Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus. Lupus. 2004; 13(1):64-9.
    View in: PubMed
    Score: 0.016
  10. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life? Lupus. 2004; 13(12):924-6.
    View in: PubMed
    Score: 0.016
  11. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol. 2002 Sep; 29(9):1907-13.
    View in: PubMed
    Score: 0.014
  12. Unique Sjögren's syndrome patient subsets defined by molecular features. Rheumatology (Oxford). 2020 04 01; 59(4):860-868.
    View in: PubMed
    Score: 0.012
  13. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
    View in: PubMed
    Score: 0.011
  14. Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus. Mol Med. 2018 06 01; 24(1):24.
    View in: PubMed
    Score: 0.011
  15. Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE. Lupus. 2015 Oct; 24(11):1169-76.
    View in: PubMed
    Score: 0.008
  16. Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjögren's syndrome. J Rheumatol. 1994 Nov; 21(11):2039-45.
    View in: PubMed
    Score: 0.008
  17. Racial differences in treatment preferences among lupus patients: a two-site study. Clin Exp Rheumatol. 2014 Sep-Oct; 32(5):680-8.
    View in: PubMed
    Score: 0.008
  18. Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model. Lupus. 2013 Sep; 22(10):1038-45.
    View in: PubMed
    Score: 0.008
  19. Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. J Rheumatol. 2012 Aug; 39(8):1632-40.
    View in: PubMed
    Score: 0.007
  20. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol. 2011; 2011:802581.
    View in: PubMed
    Score: 0.007
  21. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res (Hoboken). 2011 Jun; 63(6):865-74.
    View in: PubMed
    Score: 0.006
  22. Network analysis of associations between serum interferon-a activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum. 2011 Apr; 63(4):1044-53.
    View in: PubMed
    Score: 0.006
  23. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol. 2011 Feb 01; 186(3):1849-60.
    View in: PubMed
    Score: 0.006
  24. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan; 62(1):222-33.
    View in: PubMed
    Score: 0.006
  25. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun. 2009 Jul; 10(5):487-94.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.